Certificate

Brand

NGenebio

Product Type

Instrument

Highlights

This is a precision diagnosis panel to detect major genetic variations related to malignant tumors in blood using NGS technology.

Specifications

Certification Korean Ministry of Food and Drug Safety (MFDS) license of in-vitro diagnostic device manufacturing (License No. 20-398)
CE-IVD
Compatible platforms Illumina / MiSeq, MiSeq Dx
Target enrichment Targeted sequencing / Hyb & capture method
Specimen Blood, bone marrow and lymph nodes
Quantity 96 tests/kit (8 runs per kit, up to 12 samples per run)
Target genes 108 genes
Target size 305 kb
Turn around time 2 ~ 3 days
Variants type SNV, INDEL
Analysis solution NGeneAnalySys

Related Products

TruSight Tumor 26

TruSight Tumor 26 Kit include reagents to prepare for Library preparation samples, sequencing 26 genes relating to solid cancer, variant of  soma in NGS – Next Generation Sequencing of Illumina

Next Generation Sequencing System – MiSeq

Model: MiSeq
Manufacturer: Illumina/USA
– The MiSeq System combines cluster generation, amplification, sequencing and data analysis on a single system
– The system is most widely used, with next-generation sequencing technology –  Sequencing by Synthesis – SBS